Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice

DMM Disease Models and Mechanisms

Volumn 7, Issue 6, 2014, Pages 625-633

  Anderson, Nicholas J ^a   King, Matthew R ^a   Delbruck, Lina ^a   Jolivalt, Corinne G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glucose; High fat diet; Insulin; Neuropathy

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; CHOLESTEROL; CYCLOPHILIN B; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR; SYNAPTOPHYSIN; TAU PROTEIN; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARNES MAZE TEST; C57BL 6 MOUSE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HIPPOCAMPUS; HYPERALGESIA; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LEARNING DISORDER; LIPID DIET; LOW FAT DIET; MEMORY CONSOLIDATION; MEMORY DISORDER; MOTOR NERVE CONDUCTION; MOUSE; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STRAIN DIFFERENCE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SWISS WEBSTER MOUSE; TEMPERATURE SENSITIVITY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; COMPLICATION; METABOLISM; NEUROLOGIC DISEASE; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; DYSLIPIDEMIAS; INSULIN; MICE; MICE, INBRED C57BL; NERVOUS SYSTEM DISEASES; SIGNAL TRANSDUCTION;

EID: 84902247813     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.015750     Document Type: Article

References (62)

1. Ahima, R. S. (2006). Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity (Silver Spring) 14 Suppl. 1, 9S-15S.
2. Ansquer, J. C., Foucher, C., Aubonnet, P. and Le Malicot, K. (2009). Fibrates and microvascular complications in diabetes - insight from the FIELD study. Curr. Pharm. Des. 15, 537-552.
3. Baron, R., Tölle, T. R., Gockel, U., Brosz, M. and Freynhagen, R. (2009). A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain 146, 34-40.
4. Biessels, G. J., Deary, I. J. and Ryan, C. M. (2008). Cognition and diabetes: a lifespan perspective. Lancet Neurol. 7, 184-190.
5. Calcutt, N. A. (2004). Modeling diabetic sensory neuropathy in rats. Methods Mol. Med. 99, 55-65.
6. Calcutt, N. A., Cooper, M. E., Kern, T. S. and Schmidt, A. M. (2009). Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat. Rev. Drug Discov. 8, 417-430.
7. Callaghan, B. C., Feldman, E., Liu, J., Kerber, K., Pop-Busui, R., Moffet, H. and Karter, A. J. (2011). Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care 34, 635-640.
8. Chan, K. H., Lam, K. S., Cheng, O. Y., Kwan, J. S., Ho, P. W., Cheng, K. K., Chung, S. K., Ho, J. W., Guo, V. Y. and Xu, A. (2012). Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity. PLoS ONE 7, e52354.
9. Cholerton, B., Baker, L. D. and Craft, S. (2013). Insulin, cognition, and dementia. Eur. J. Pharmacol. 719, 170-179.
10. Clemens, A., Siegel, E. and Gallwitz, B. (2004). Global risk management in type 2 diabetes: blood glucose, blood pressure, and lipids - update on the background of the current guidelines. Exp. Clin. Endocrinol. Diabetes 112, 493-503. (Pubitemid 39457626)
11. Craft, S. (2005). Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol. Aging 26 Suppl. 1, 65-69.
12. Craft, S. (2009). The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch. Neurol. 66, 300-305.
13. Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., Haneuse, S., Craft, S., Montine, T. J., Kahn, S. E. et al. (2013). Glucose levels and risk of dementia. N. Engl. J. Med. 369, 540-548.
14. Cukierman, T., Gerstein, H. C. and Williamson, J. D. (2005). Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies. Diabetologia 48, 2460-2469. (Pubitemid 41738208)
15. Desrocher, M. and Rovet, J. (2004). Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol. 10, 36-52. (Pubitemid 38418932)
16. Ferguson, S. C., Blane, A., Perros, P., McCrimmon, R. J., Best, J. J., Wardlaw, J., Deary, I. J. and Frier, B. M. (2003). Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52, 149-156. (Pubitemid 36042120)
17. Gabbay, K. H. (1973). The sorbitol pathway and the complications of diabetes. N. Engl. J. Med. 288, 831-836.
18. Groover, A. L., Ryals, J. M., Guilford, B. L., Wilson, N. M., Christianson, J. A. and Wright, D. E. (2013). Exercise-mediated improvements in painful neuropathy associated with prediabetes in mice. Pain 154, 2658-2667.
19. Gustafson, D. (2012). Adiposity and cognitive decline: underlying mechanisms. J. Alzheimers Dis. 30 Suppl. 2, S97-S112.
20. Huang, Z., Yin, Q., Sun, W., Zhu, W., Li, Y., Liu, W., Xiao, L., Duan, Z., Cai, Q., Liu, D. et al. (2013). Microbleeds in ischemic stroke are associated with lower serum adiponectin and higher soluble E-selectin levels. J. Neurol. Sci. 334, 83-87.
21. Jolivalt, C. G., Lee, C. A., Beiswenger, K. K., Smith, J. L., Orlov, M., Torrance, M. A. and Masliah, E. (2008). Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J. Neurosci. Res. 86, 3265-3274.
22. Jolivalt, C. G., Hurford, R., Lee, C. A., Dumaop, W., Rockenstein, E. and Masliah, E. (2010). Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp. Neurol. 223, 422-431.
23. Kamiya, H., Murakawa, Y., Zhang, W. and Sima, A. A. (2005). Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes. Diabetes Metab. Res. Rev. 21, 448-458. (Pubitemid 41320656)
24. Kato, K., Osawa, H., Ochi, M., Kusunoki, Y., Ebisui, O., Ohno, K., Ohashi, J., Shimizu, I., Fujii, Y., Tanimoto, M. et al. (2008). Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin. Endocrinol. (Oxf.) 68, 442-449. (Pubitemid 351257865)
25. Kim, M.-J. and Kim, H. (2012). Insulinotrophic and hypolipidemic effects of Ecklonia cava in streptozotocin-induced diabetic mice. Asian Pac. J. Trop. Med. 5, 374-379.
26. King, M. R., Anderson, N. J., Guernsey, L. S. and Jolivalt, C. G. (2013). Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice. J. Neurosci. Res. 91, 506-514.
27. Kobayashi, H., Ouchi, N., Kihara, S., Walsh, K., Kumada, M., Abe, Y., Funahashi, T. and Matsuzawa, Y. (2004). Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94, e27-e31.
28. Lara-Castro, C., Luo, N., Wallace, P., Klein, R. L. and Garvey, W. T. (2006). Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55, 249-259. (Pubitemid 43343322)
29. Lee-Kubli, C., Mixcoatl-Zecuatl, T., Jolivalt, C. G. and Calcutt, N. A. (2014). Animal models of diabetes-induced neuropathic pain. In Current Topics in Behavioral Neurosciences (ed. M. Geyer, B. Ellenbroek and C. Marsden). Berlin; Heidelberg: Springer-Verlag (in press).
30. Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C. and Palumbo, P. J. (1997). Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am. J. Epidemiol. 145, 301-308. (Pubitemid 27082028)
31. Manschot, S. M., Brands, A. M., van der Grond, J., Kessels, R. P., Algra, A., Kappelle, L. J., Biessels, G. J.; Utrecht Diabetic Encephalopathy Study Group (2006). Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55, 1106-1113. (Pubitemid 44100188)
32. Matsuda, M., Kawasaki, F., Inoue, H., Kanda, Y., Yamada, K., Harada, Y., Saito, M., Eto, M., Matsuki, M. and Kaku, K. (2004). Possible contribution of adipocytokines on diabetic neuropathy. Diabetes Res. Clin. Pract. 66 Suppl. 1, S121-S123. (Pubitemid 39572597)
33. McCarthy, A. M., Lindgren, S., Mengeling, M. A., Tsalikian, E. and Engvall, J. C. (2002). Effects of diabetes on learning in children. Pediatrics 109, e9.
34. McNay, E. C. and Recknagel, A. K. (2011). Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiol. Learn. Mem. 96, 432-442.
35. McNay, E. C., Ong, C. T., McCrimmon, R. J., Cresswell, J., Bogan, J. S. and Sherwin, R. S. (2010). Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol. Learn. Mem. 93, 546-553.
36. McNeilly, A. D., Williamson, R., Sutherland, C., Balfour, D. J. and Stewart, C. A. (2011). High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behav. Brain Res. 217, 134-141.
37. Mielke, J. G., Nicolitch, K., Avellaneda, V., Earlam, K., Ahuja, T., Mealing, G. and Messier, C. (2006). Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice. Behav. Brain Res. 175, 374-382. (Pubitemid 44781116)
38. Moroz, N., Tong, M., Longato, L., Xu, H. and de la Monte, S. M. (2008). Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J. Alzheimers Dis. 15, 29-44.
39. Obrosova, I. G., Ilnytska, O., Lyzogubov, V. V., Pavlov, I. A., Mashtalir, N., Nadler, J. L. and Drel, V. R. (2007). High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. Diabetes 56, 2598-2608. (Pubitemid 47523268)
40. Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y. and Libby, P. (2006). Adiponectin: a key adipocytokine in metabolic syndrome. Clin. Sci. (Lond.) 110, 267-278. (Pubitemid 43341630)
41. Ott, A., Stolk, R. P., Hofman, A., van Harskamp, F., Grobbee, D. E. and Breteler, M. M. (1996). Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39, 1392-1397. (Pubitemid 26356072)
42. Pákáski, M., Fehér, A., Juhász, A., Drótos, G., Fazekas, O. C., Kovács, J., Janka, Z. and Kálmán, J. (2014). Serum adipokine levels modified by donepezil treatment in Alzheimer's disease. J. Alzheimers Dis. 38, 371-377.
43. Pancani, T., Anderson, K. L., Brewer, L. D., Kadish, I., DeMoll, C., Landfield, P. W., Blalock, E. M., Porter, N. M. and Thibault, O. (2013). Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats. Neurobiol. Aging 34, 1977-1987.
44. Papanas, N. and Ziegler, D. (2012). Prediabetic neuropathy: does it exist? Curr. Diab. Rep. 12, 376-383.
45. Peila, R., Rodriguez, B. L., Launer, L. J.; Honolulu-Asia Aging Study (2002). Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262. (Pubitemid 34438377)
46. Piercy, V., Banner, S. E., Bhattacharyya, A., Parsons, A. A., Sanger, G. J., Smith, S. A. and Bingham, S. (1999). Thermal, but not mechanical, nociceptive behavior is altered in the Zucker Diabetic Fatty rat and is independent of glycemic status. J. Diabetes Complications 13, 163-169. (Pubitemid 29430217)
47. Ramos-Rodriguez, J. J., Ortiz, O., Jimenez-Palomares, M., Kay, K. R., Berrocoso, E., Murillo-Carretero, M. I., Perdomo, G., Spires-Jones, T., Cozar-Castellano, I., Lechuga-Sancho, A. M. et al. (2013). Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. Psychoneuroendocrinology 38, 2462-2475.
48. Reaven, G. M., Thompson, L. W., Nahum, D. and Haskins, E. (1990). Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13, 16-21. (Pubitemid 20024725)
49. Revill, P., Moral, M. A. and Prous, J. R. (2006). Impaired insulin signaling and the pathogenesis of Alzheimer's disease. Drugs Today (Barc) 42, 785-790.
50. Ronnemaa, E., Zethelius, B., Sundelof, J., Sundstrom, J., Degerman-Gunnarsson, M., Lannfelt, L., Berne, C. and Kilander, L. (2009). Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men. Diabetologia 52, 1504-1510.
51. Ryan, C. M. and Williams, T. M. (1993). Effects of insulin-dependent diabetes on learning and memory efficiency in adults. J. Clin. Exp. Neuropsychol. 15, 685-700.
52. Ryan, C., Vega, A. and Drash, A. (1985). Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75, 921-927.
53. Sahin, M., Karatas, M., Sahin, M., Ertugrul, D., Kulaksizoǧlu, M., Dogruk, A., Gokcel, A., Tutuncu, N. B., Guvener, N. D. and Kutlu, M. (2008). High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels. Minerva Endocrinol. 33, 289-296.
54. Takeuchi, S., Wada, K., Nawashiro, H., Uozumi, Y., Otani, N., Nagatani, K., Kobayashi, H. and Shima, K. (2013). Decrease in plasma adiponectin level and increase in adiponectin immunoreactivity in cortex and hippocampus after traumatic brain injury in rats. Turk. Neurosurg. 23, 349-354.
55. Teixeira, A. L., Diniz, B. S., Campos, A. C., Miranda, A. S., Rocha, N. P., Talib, L. L., Gattaz, W. F. and Forlenza, O. V. (2013). Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease. Neuromolecular Med. 15, 115-121.
56. van Himbergen, T. M., Beiser, A. S., Ai, M., Seshadri, S., Otokozawa, S., Au, R., Thongtang, N., Wolf, P. A. and Schaefer, E. J. (2012). Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Arch. Neurol. 69, 594-600.
57. Velayudhan, L., Poppe, M., Archer, N., Proitsi, P., Brown, R. G. and Lovestone, S. (2010). Risk of developing dementia in people with diabetes and mild cognitive impairment. Br. J. Psychiatry 196, 36-40.
58. Vincent, A. M., Hayes, J. M., McLean, L. L., Vivekanandan-Giri, A., Pennathur, S. and Feldman, E. L. (2009). Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 58, 2376-2385.
59. Warren, M. W., Hynan, L. S. and Weiner, M. F. (2012). Lipids and adipokines as risk factors for Alzheimer's disease. J. Alzheimers Dis. 29, 151-157.
60. Watcho, P., Stavniichuk, R., Ribnicky, D. M., Raskin, I. and Obrosova, I. G. (2010). High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L. Mediators Inflamm. 2010, 268547.
61. Wiggin, T. D., Sullivan, K. A., Pop-Busui, R., Amato, A., Sima, A. A. and Feldman, E. L. (2009). Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58, 1634-1640.
62. Xu, W. L., von Strauss, E., Qiu, C. X., Winblad, B. and Fratiglioni, L. (2009). Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia 52, 1031-1039.